These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21737547)

  • 1. Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations.
    Berghmans T; Pasleau F; Paesmans M; Bonduelle Y; Cadranel J; Cs Toth I; Garcia C; Giner V; Holbrechts S; Lafitte JJ; Lecomte J; Louviaux I; Markiewicz E; Meert AP; Richez M; Roelandts M; Scherpereel A; Tulippe Ch; Van Houtte P; Van Schil P; Wachters C; Westeel V; Sculier JP;
    Eur Respir J; 2012 Jan; 39(1):9-28. PubMed ID: 21737547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Management of resectable non-small cell lung cancer. Guidelines of clinical practice made by the European Lung Cancer Working Party].
    Sculier JP;
    Rev Med Brux; 2014; 35(3):134-9. PubMed ID: 25102579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review and Canadian consensus recommendations on the use of biomarkers in the treatment of non-small cell lung cancer.
    Ellis PM; Blais N; Soulieres D; Ionescu DN; Kashyap M; Liu G; Melosky B; Reiman T; Romeo P; Shepherd FA; Tsao MS; Leighl NB
    J Thorac Oncol; 2011 Aug; 6(8):1379-91. PubMed ID: 21709590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of proteomics in non-small-cell lung cancer.
    Cho WC
    Expert Rev Proteomics; 2016; 13(1):1-4. PubMed ID: 26577456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surrogate endpoints for overall survival in lung cancer trials: a review.
    Fiteni F; Westeel V; Bonnetain F
    Expert Rev Anticancer Ther; 2017 May; 17(5):447-454. PubMed ID: 28399678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
    Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
    Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Postmus PE; Kerr KM; Oudkerk M; Senan S; Waller DA; Vansteenkiste J; Escriu C; Peters S;
    Ann Oncol; 2017 Jul; 28(suppl_4):iv1-iv21. PubMed ID: 28881918
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.
    Califano R; Karamouzis MV; Banerjee S; de Azambuja E; Guarneri V; Hutka M; Jordan K; Kamposioras K; Martinelli E; Corral J; Postel-Vinay S; Preusser M; Porcu L; Torri V
    Lung Cancer; 2014 Jul; 85(1):74-80. PubMed ID: 24746176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time courses and value of circulating microparticles in patients with operable stage non-small cell lung cancer undergoing surgical intervention.
    Tseng CC; Wang CC; Hsiao CC; Lu HI; Leu S; Chang HC; Huang KT; Fang WF; Chen YM; Liu SF; Yang CT; Lin MC; Yip HK
    Tumour Biol; 2016 Sep; 37(9):11873-11882. PubMed ID: 27059732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of unresectable non-metastatic non-small cell lung cancer. Guidelines of clinical practice made by the European Lung Cancer Working Party].
    Paesmans M;
    Rev Med Brux; 2014; 35(3):140-4. PubMed ID: 25102580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-small cell lung cancer clinical practice guidelines in oncology.
    Ettinger DS; Bepler G; Bueno R; Chang A; Chang JY; Chirieac LR; D'Amico TA; Demmy TL; Feigenberg SJ; Grannis FW; Jahan T; Jahanzeb M; Kessinger A; Komaki R; Kris MG; Langer CJ; Le QT; Martins R; Otterson GA; Robert F; Sugarbaker DJ; Wood DE;
    J Natl Compr Canc Netw; 2006 Jul; 4(6):548-82. PubMed ID: 16813724
    [No Abstract]   [Full Text] [Related]  

  • 12. Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer.
    Tanaka S; Hattori N; Ishikawa N; Shoda H; Takano A; Nishino R; Okada M; Arihiro K; Inai K; Hamada H; Yokoyama A; Kohno N
    Int J Cancer; 2012 Jan; 130(2):377-87. PubMed ID: 21351094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACR appropriateness criteria nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intent.
    Rosenzweig KE; Chang JY; Chetty IJ; Decker RH; Ginsburg ME; Kestin LL; Kong FM; Lally BE; Langer CJ; Movsas B; Videtic GM; Willers H
    J Am Coll Radiol; 2013 Sep; 10(9):654-64. PubMed ID: 23890874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic strategies in patients undergoing surgery for non-small cell lung cancer. Results of the ESCAP-2011-CPHG study, promoted by the French College of General Hospital Respiratory Physicians (CPHG)].
    Pinquié F; Goupil F; Oster JP; Dixmier A; Renault PA; Lévy A; Mathieu JP; Paillot N; Goutorbe FC; Masson P; Molinier O; Debieuvre D; Grivaux M
    Rev Mal Respir; 2017 Nov; 34(9):976-990. PubMed ID: 29150179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.
    J Clin Oncol; 1997 Aug; 15(8):2996-3018. PubMed ID: 9256144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Not Available].
    Klee H
    Pneumologie; 2016 Dec; 70(12):835. PubMed ID: 27931060
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum levels of surfactant protein D predict the anti-tumor activity of gefitinib in patients with advanced non-small cell lung cancer.
    Yamaguchi H; Soda H; Nakamura Y; Takasu M; Tomonaga N; Nakano H; Doi S; Nakatomi K; Nagashima S; Takatani H; Fukuda M; Hayashi T; Tsukamoto K; Kohno S
    Cancer Chemother Pharmacol; 2011 Feb; 67(2):331-8. PubMed ID: 20401612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current topics in pulmonary oncology].
    Sculier JP; Berghmans T; Vermylen P; Ninane V
    Rev Med Brux; 1997 Sep; 18(4):204-8. PubMed ID: 9411643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating MACC1 as a novel diagnostic and prognostic biomarker for nonsmall cell lung cancer.
    Wang Z; Cai M; Weng Y; Zhang F; Meng D; Song J; Zhou H; Xie Z
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1353-61. PubMed ID: 25544672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of unresectable non-metastatic non-small cell lung cancer. Guidelines of clinical practice made by the European Lung Cancer Working Party].
    European Lung Cancer Working Party
    Rev Med Brux; 2006; 27(3):152-61. PubMed ID: 16894953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.